UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Laura Mitic, PhD, is the Chief Scientific Officer at the Bluefield Project to Cure Frontotemporal Dementia. Dr. Mitic holds a BA degree from Northwestern University and a doctorate degree in cell biology from Yale University. She completed postdoctoral studies at the University of California, San Francisco. She and her husband live in San Francisco with their two children.
Sabrina (Erlhoff) Jarrott manages the development and implementation of the TabCAT software platform. TabCAT is a technologically and scientifically robust system for the administration of novel cognitive and behavioral assessment measures aimed at advancing early detection and monitoring of neurocognitive disorders developed by Dr. Kate Possin.
Dr. Kate Rankin is a professor in the UCSF Department of Neurology who specializes in the neuropsychological, neuroanatomic and genetic underpinnings of human socioemotional behavior in healthy aging and neurodegenerative disease. She studied psychology at Yale for her undergraduate work and received graduate degrees from Fuller School of Psychology in Pasadena, including her PhD degree in clinical psychology and a master’s degree in theology.
Christine M. Walsh, PhD, received her BA degree in physiology from Trinity College Dublin, University of Dublin in Ireland. Dr. Walsh did her doctoral work at the University of Michigan studying the effects of REM sleep modulation on learning and memory. She also studied the neural correlates of cognitive aging. In 2011 Dr. Walsh joined the UCSF Memory and Aging Center where she has been studying sleep in both healthy older adults and in individuals with neurodegenerative diseases. Dr. Walsh is particularly interested in the contribution of sleep disturbance to cognitive decline.
Jennifer Yokoyama obtained her doctorate degree in Pharmaceutical Sciences and Pharmacogenomics from UCSF in December 2010 with Dr. Steven Hamilton (Department of Psychiatry and Institute for Human Genetics). Her dissertation comprised work within the Canine Behavioral Genetics Project, utilizing purebred dogs as genetic models for studying neuropsychiatric disease. Utilizing community-based canine DNA samples, Dr.
Dr. Mary De May received her medical degree from the State University of New York at Stony Brook. She completed an internship in medicine and psychiatry at the University of Pennsylvania in Philadelphia and subsequently did her psychiatry residency and fellowship at the University of Pittsburgh Western Psychiatric Institute and Clinic. She joined the UCSF Memory and Aging Center in 2000, where she is the center’s Hellman Master Clinician and the Hellman Family Distinguished Professor of Neurology.
Dr. Lea Tenenholz Grinberg is a neuropathologist specializing in brain aging and associated disorders, most notably, Alzheimer’s disease and the neurological basis of sleep disturbances in neurodegenerative diseases. Currently, she is a John Douglas French Alzheimer’s Foundation Endowed Professor at the UCSF Memory and Aging Center, part of the Executive Board of the Global Brain Health Institute and a member of the Medical Scientific Advisory Group for the Alzheimer’s Association.
Dr. Kamalini Ranasinghe received her medical degree from the University of Peradeniya, Sri Lanka and completed her internship training in general medicine and general surgery. She earned her doctorate degree in Cognition and Neuroscience from the University of Texas at Dallas, under the mentorship of Dr. Michael Kilgard.